Mutual of America Capital Management’s SpringWorks Therapeutics SWTX Stock Holding History

Mutual of America Capital Management’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-144,245	Closed	-$6.37M	–	1416
2025 Q1	$6.37M	Buy	144,245 +27,313	+23%	+$1.26M	0.07%	308
2024 Q4	$4.22M	Buy	116,932 +1,898	+2%	+$66.3K	0.05%	540
2024 Q3	$3.69M	Sell	115,034 -1,881	-2%	-$70.3K	0.04%	632
2024 Q2	$4.4M	Buy	116,915 +34,260	+41%	+$1.44M	0.05%	517
2024 Q1	$4.07M	Buy	82,655 +18,441	+29%	+$853K	0.04%	588
2023 Q4	$2.34M	Buy	+64,214	New	+$1.68M	0.03%	837

Other funds holding SWTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return

Mutual of America Capital Management's SWTX Position: Q2 2025 in Review

Mutual of America Capital Management sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 144,245 shares — an estimated $6.37M sold.

Mutual of America Capital Management first reported a position in SWTX in Q4 2023 and held it in 6 quarters. The position peaked at $6.37M in Q1 2025. 222 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

Mutual of America Capital Management reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
Mutual of America Capital Management sold 144,245 SpringWorks Therapeutics shares in Q2 2025, an estimated $6.37M.
Mutual of America Capital Management first reported a position in SpringWorks Therapeutics in Q4 2023 and held it in 6 quarters.
Mutual of America Capital Management's SpringWorks Therapeutics position peaked at $6.37M in Q1 2025.
222 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on Mutual of America Capital Management's 13F filing for Q2 2025, filed 29 Jul 2025.